Skip to content

Usefulness and safety of EUS-BD for malignant bile duct obstruction difficult to treat with ERCP in the community;prospective cohort study

Usefulness and safety of EUS-BD for malignant bile duct obstruction difficult to treat with ERCP in the community;prospective cohort study - Usefulness and safety of EUS-BD for cases difficult to treat with ERCP in the community:prospective cohort study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000030476
Enrollment
40
Registered
2017-12-20
Start date
2017-07-10
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with malignant biliary obstruction difficult to treat by ERCP

Interventions

None listed

Sponsors

Wakayama Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: over 20 years old Cases requiring biliary duct drainage Cases with biliary obstruction by malignant tumor Cases in which biliary drainage by ERCP was unsuccessful at regional hospitals

Exclusion criteria

Exclusion criteria: Cases which endoscopes can not be done Informed consent can not be obtained Cases scheduled for radical surgery Cases judged by investigator as inappropriate as subjects

Design outcomes

Primary

MeasureTime frame
Internal fistula rate of biliary stent

Countries

Japan

Contacts

Public ContactTakashi Tamura

Wakayama Medical University Second Department of Internal Medicine

ttakashi@wakayama-med.ac.jp073-447-2300

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026